Advancing The Possibilities Of Protein Engineering Into The Future

This content is brought to you by Integrated DNA Technologies, a Danaher Operating Company.

Biotechnology is entering a phase where designing proteins is becoming faster, more precise, and increasingly data-driven. Advances in DNA synthesis, CRISPR gene editing, and next-generation sequencing are converging with artificial intelligence to shift workflows from discovery-based screening to intentional, de novo design. High-quality gene fragments are reducing bottlenecks, enabling faster construct assembly and more efficient protein development. These capabilities are already driving meaningful progress, from improving gene editing accuracy and accelerating drug discovery to enabling sustainable solutions in agriculture and industrial processes. As access to sequence data expands and tools mature, protein engineering is positioned to unlock entirely new applications across industries.

Gain insight into how emerging technologies and streamlined workflows are reshaping what’s possible, as well as what comes next for protein design.